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Foxa1, 2 and 3 (formerly HNF-3α, -β and -γ) constitute a sub-family of winged helix transcription factors with multiple roles in mammalian
organ development. While all three Foxa mRNAs are present in endoderm derivatives including liver and pancreas, only Foxa3 is expressed in
the testis. Here we demonstrate by genetic lineage tracing that Foxa3 is expressed in postmeiotic germ and interstitial Leydig cells. The germinal
epithelium of Foxa3-deficient testes is characterized by a loss of germ cells secondary to an increase in germ cell apoptosis that ultimately leads to
a Sertoli cell-only syndrome. Remarkably, not only the Foxa3−/− mice but also Foxa3+/− mice exhibited loss of germ cells. This cellular
phenotype caused significantly reduced fertility and testis weight of both Foxa3−/− and Foxa3+/− mice. Using microarray analysis, we found a
dramatic downregulation of the zinc finger protein 93 and the testicular tumor-associated paraneoplastic Ma antigen (PNMA) and increased
expression of a number of genes including zinc finger protein 94 and several kallikrein 1-related peptidases which could account for at least part of
the observed phenotype. In summary, we have identified Foxa3 as a transcriptional regulator with a dominant phenotype in germ cell maintenance
and suggest FOXA3 as a potential candidate gene for subfertility in man.
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Paracrine signallingIntroduction
Subfertility and infertility in men are widespread yet poorly
understood health problems. Approximately 15% of all couples
of reproductive age are infertile, and the causes of infertility are
roughly equally distributed between genders (Nieschlag, 2001).
Germ cell production in the mammalian testis depends on
intimate biochemical and physical interactions between somatic
Sertoli cells and germ cells (Mruk and Cheng, 2004; Sharpe et
al., 2003). In addition, normal Leydig cell function is also
critical for proper sperm production in rodents and men
(Andersson et al., 2004; Qian et al., 2001; Rich et al., 1979).
Hence, it is well established that there is a functional network
between the somatic cell types, i.e. the Sertoli and the Leydig
cells, and the germ cells (Gnessi et al., 1997, 2000; Huleihel and⁎ Corresponding author. Fax: +1 215 573 5892.
E-mail address: kaestner@mail.med.upenn.edu (K.H. Kaestner).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.03.525Lunenfeld, 2004; Jegou et al., 1984; O'Donnell et al., 2001;
Weinbauer and Wessels, 1999).
Spermatogenesis can be divided into three phases: phase 1
consists of up to eleven mitotic divisions of the germinal
stem cells (i.e. the spermatogonia), phase 2, which is meiosis
of the spermatogonia, and phase 3, which comprises the
postmeiotic differentiation of the haploid spermatids. Thus,
theoretically each germinal stem cell division can result in the
production of several thousand sperm cells (de Rooij, 2001).
Due to the exponential nature of the process even a small
decrease in the efficiency of spermatogonial proliferation or
survival, caused for instance by abnormal Sertoli or Leydig
cell function, can result in a dramatic reduction in sperm
count and fertility.
While gene targeting studies in mice have identified many
factors as being important in spermatogenesis (Cooke and
Saunders, 2002; de Rooij and de Boer, 2003; Escalier, 2001;
Matzuk and Lamb, 2002; Venables and Cooke, 2000), none of
the Fox (Forkhead box) or winged helix DNA binding proteins
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demonstrate using genetic lineage tracing analysis that the
transcription factor Foxa3, previously known as hepatocyte
nuclear factor 3γ or HNF-3γ, is expressed in Leydig cells and in
spermatids. Mice either homozygous or heterozygous for a
Foxa3 null allele exhibit reduced male fertility secondary to
increased germ cell apoptosis. We identify several candidate
genes possibly linking the lack of Foxa3 with the observed
phenotype and conclude that Foxa3 plays an important role in
the maintenance of a healthy germinal epithelium. We suggest
that mutations in the human FOXA3 gene might contribute to
subfertility in man.
Results and discussion
Foxa3 is expressed in Leydig cells and in spermatids
Foxa3 is the only member of the Foxa subfamily of trans-
cription factors expressed in testes, and, as such, a candidate
gene for a regulator of spermatogenesis (Kaestner et al., 1994;
Lai et al., 1991). Foxa3 mRNA was expressed from day 6 to
day 70 during postnatal testicular development in the mouse
(Fig. 1a), suggesting a role for Foxa3 in testicular development
as well as the maintenance of the adult status. Because none of
the available antibodies produced consistent staining patterns
that were absent from Foxa3 null tissue (data not shown), we
decided to localize Foxa3 expression further by genetic
lineage tracing. In genetic lineage tracing (see scheme in
Fig. 1b), the control elements of the gene of interest, here
Foxa3, are used to drive the site-specific DNA recombinase
Cre. In all cells where Cre is expressed, a loxP flanked stop
sequence is removed, allowing for the expression of a marker
gene, in our case β-galactosidase. Because the Cre activity
produces a permanent mark in the genome, all descendants of
the first cell that expressed Cre will be labeled as well. An
essential requirement for this technique is a Cre transgene that
accurately mimics the expression of the endogenous gene.
Therefore, we employed a 170 kb yeast artificial chromosome
(YAC) encompassing the entire Foxa3 locus to direct
expression of Cre, as this transgene has been shown to
faithfully recapitulate the expression of the endogenous Foxa3
gene (Hiemisch et al., 1997; Lee et al., 2005). As shown in
Figs. 1d and e, both Leydig cells and spermatids were β-
galactosidase positive in Foxa3Cre/Rosa26 reporter mice. No
staining was observed in Rosa26 reporter mice alone (Fig. 1c).
Not all Leydig cells were positive for lacZ in Foxa3Cre/
Rosa26 reporter mice, which most likely reflects the hetero-
geneous physiological state of Leydig cells. For instance, it is
well established that Leydig cells also differ in the expression
of the androgen receptor (AR), with a subpopulation of Leydig
cells expressing no AR (Vornberger et al., 1994). Foxa3Cre
expression in spermatids as evidenced by β-galactosidase
staining starts shortly before nuclear condensation of sperma-
tids. However, as judged by the phenotype of Foxa3-deficient
mice described below, Foxa3 expression in spermatids is of
minor physiological importance compared to its expression in
Leydig cells.Foxa3 mutant mice show abnormal testicular development
Next we investigated testicular development in Foxa3
mutant mice. In contrast to normal mice, aging Foxa3-deficient
testes could not support spermatogenesis throughout the entire
germinal epithelium (Fig. 2). At the postnatal age of 40 days,
when the testis produces the first sperm cells, no histological
defects were seen in Foxa3 mutant mice (data not shown). In
Foxa3-deficient testes of 3-month-old mice a few abnormal,
but no completely degenerated tubules were visible (Figs. 2a
and b). During the next months, the phenotype became more
pronounced and in 8-month-old mice a significant portion of
tubules was degenerated (Figs. 2c and d). In mice older than
1 year about a third of all tubular cross sections exhibited
severe impairment of spermatogenesis. While the mutant testes
at any age also contained tubules with apparently normal
spermatogenesis, directly adjacent tubules were often degen-
erating (Figs. 2d and e) or completely devoid of germ cells
(Fig. 2f). Degenerating tubules were randomly distributed over
the testes. Remarkably, the last remaining germ cells in
degenerating tubules were elongated spermatids and mature
sperm cells (Fig. 2e). This indicates that the observed
phenotype is likely caused by impairment of early germ cell
proliferation or survival, and not by a specific block during
sperm maturation, even though Foxa3 is expressed during
spermiogenesis. After passing an early critical checkpoint, the
developing germ cells can complete meiosis and spermiogen-
esis, even if the following germ cell generations are completely
missing and the germinal epithelium is almost atrophied (Fig.
2e). Hence, histologically, the lack of Foxa3 in spermatids does
not affect spermiogenesis. At the late stages of tubular
degeneration as seen in Fig. 2f, some of the Sertoli cell nuclei
have lost the pyramidal shape normally found in Sertoli cells
supporting ongoing spermatogenesis.
Foxa3 mutant testes exhibit increased apoptosis in the
germinal epithelium
The maintenance of a normally composed germinal
epithelium depends on a finely tuned balance between pro-
liferation, differentiation, and apoptosis of the germ cells (de
Rooij, 2001). We analyzed germ cell proliferation using BrdU
incorporation as a marker for DNA synthesis in replicating
cells. At 2 h after injection mitotically dividing spermatogonia
and primary spermatocytes were labeled. There was no
difference in the number of BrdU-positive cells between wild
type and mutant testes (Fig. 3a), indicating that the defect in the
Foxa3−/− mice was not caused by decreased proliferation of
germ cells. Even in strongly degenerated tubules BrdU-positive
germ cells were seen. In order to quantify germ cell apoptosis
we carried out TUNEL assays on testicular tissue sections (Figs.
3b and c). We found a significantly increased number of
TUNEL-positive cells per TUNEL-positive tubular cross-
section in the Foxa3-mutant as well as in the heterozygous
testes compared to controls (p<0.02 wt vs. heterozygous and
homozygous mutants) (Fig. 3d). Furthermore, the percentage of
tubules containing TUNEL-positive cells was slightly increased
Fig. 1. Testicular expression of Foxa3. (a) Messenger RNA expression analysis by RNase protection assay. Foxa3 mRNA is detectable in the mouse testis
throughout postnatal development. The mRNA abundance is increased approximately twofold in the adult testis when compared to the 6-day-old testis
(normalized to GAPDH mRNA). RNA was prepared from testis of postnatal days 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 36, 40, and 70,
respectively. (b) Scheme of the genetic lineage tracing employed to track Foxa3 expression in the testis. Beta-galactosidase expression occurs only in those
cells that express Foxa3 or are the descendants of Foxa3-expressing cells. (c) The control mouse (Rosa26R, no Cre), shows no β-galactosidase expression in
the testes. (d, e) Mice carrying both the β-galactosidase reporter and the Foxa3-Cre transgene (Rosa26R; Foxa3Cre mice) display robust staining in Leydig
cells (red arrowheads) and in spermatids (arrows).
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tubules). Altogether, the number of apoptotic germ cells in the
Foxa3-deficient testes was increased 1.77-fold. This differencebecomes even more relevant taking in consideration that mostly
spermatogonia are affected by apoptosis as judged from the
position of the labeled cells in the germinal epithelium. The
Fig. 2. Testicular degeneration in Foxa3-deficient mouse testes. (a) Histological section of a wild type mouse testis at the age of 3 months. All seminiferous tubules
contain somatic Sertoli cells as well as germ cells and exhibit ongoing germ cell production. (b)Mutant testis at the age of 3 months. Sporadic tubulus with early signs of
degeneration, i.e. thinning of the germinal epithelium, can be seen (arrow). (c) Histological section of a wild type mouse testis at the age of 8 months showing normal
spermatogenesis in all tubules. (d–f) Histological sections of Foxa3-deficient mouse testes at 8 months of age. The testis contains both tubules with normal appearance
and ongoing spermatogenesis as well as severely degenerated tubules. The characteristic feature of the defective tubules is a selective loss of germ cells. The Sertoli cells
remained within the tubule resulting in a focal Sertoli cell-only syndrome. (e) An almost completely atrophied seminiferous tubule. The only germ cells present are
elongated spermatids. All spermatogonia, spermatocytes, and round spermatids are missing. The elongated spermatids are arrayed on the adluminal surface of the Sertoli
cells as they usually are shortly before sperm release from the germinal epithelium (spermiation). (f) A Sertoli cell only tubule (bottom) adjacent to a tubule with complete
spermatogenesis (top). The Sertoli cell nuclei characterized by their triangular shape and their prominent nucleoli have aligned with the basal lamina indicating the
absence of any germ cells. Heterozygous testes show histological pictures similar to the homozygous mutant testes. Magnification of a–d=100×; e and f=600×.
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germ cell production, will result in the loss of the entire germ
cell population within a region of the germinal epithelium. Thusincreased germ cell apoptosis is expected to result in
seminiferous tubules devoid of germ cells as seen in the
Foxa3−/− mice (Fig. 2).
Fig. 4. Reduced male fertility and testis weight in Foxa3-deficient mice. (a) The
testicular defect in Foxa3-deficient mice results in reduced fertility. Male age-
matched mice of each genotype were housed together with a female CD1 wt
mouse. The average litter size in the mutant (p<0.05) and in the heterozygous
group (p<0.02) was significantly lower than in the wt group. (b) The Foxa3-
mutant (p=0.003) as well as the heterozygous (p=0.007) mice show a
significantly reduced testis weight compared to the wild type controls. Data are
presented as paired testis weight [mg] per body weight [g].
Fig. 3. Testicular proliferation and apoptosis in Foxa3-deficient mice. (a)
Proliferation rates, as determined by BrdU labeling of cells in S-phase during
spermatogenic stages VII and VIII, are not different between wild type and
Foxa3-deficient mice (p>0.35). (b) Apoptosis in a wild type mouse testis
as revealed by the TUNEL-technique. Only a minor proportion of all tubules
contains one or more TUNEL-positive cells. All other tubules are devoid of
TUNEL-positive cells. As judged from the appearance and the location of the
cells in the seminiferous tubule the apoptotic cells are almost exclusively
spermatogonia and spermatocytes. (c) Foxa3-deficient mice lose their germ
cell population by apoptosis. The tubule undergoing degeneration exhibits a
high number of apoptotic germ cells, again mainly spermatogonia and
spermatocytes. Note the already degenerated tubules which are devoid of
TUNEL-positive cells. (d) Apoptotic index expressed as TUNEL-positive cells
per tubule containing TUNEL-positive cells. The mutant as well as the
heterozygous testes show a significant increase in the number of apoptotic
cells (p<0.05).
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To test whether the morphological defects described above
had an impact on the reproductive capability of the Foxa3
mutant mice we mated 3-month-old Foxa3+/+, Foxa3+/−, and
Foxa3−/− males (n=8 in each group) for 5 months to wild type
females. Interestingly, the average litter size of the homozygous
mutant as well of the heterozygous group was significantly
smaller than in the wild type group (p<0.05) (Fig. 4a). The litter
sizes of the Foxa3+/− and Foxa3−/− groups did not differ
significantly. The biological relevance of the defect in
spermatogenesis is emphasized by the fact that not all males
were fertile in the mutant and in the heterozygous group.
The mating data correlate well with the testicular weight in
relation to body weight at 8 months of age. While this
coefficient is 6.48 for the wt group (mg paired testis weight
per g bodyweight), the coefficient for the Foxa3+/− and the
Foxa3−/− group is 5.43 and 5.10, respectively (P≤0.0001)
(Fig. 4b). The bodyweight did not differ significantly among
the three experimental groups (P≥0.2).
Hormonal analysis
Qualitatively and quantitatively normal spermatogenesis is
dependent on several hormones. We analyzed circulating FSH,
Table 1
Foxa3-dependent gene expression in testis
Affy ID Gene symbol Microarray QPCR
Fold
change
q-value
(%)
Fold
change
P-value
1439289_s_at 0710005I19Rik −4.0 0.0 −3.8 0.02
1428781_at 1110014F24Rik −4.8 0.0 −1.6 0.14
1457458_at BC057627 −3.3 3.4 −1.2 0.27
1428173_at Eml2 −2.0 3.4 −2.7 0.066
1451607_at Klk1b21 2.1 4.4 3.0 0.001
1420770_at Klk1b24 2.9 6.4 1.8 0.04
1421587_at Klk1b27 2.6 4.4 1.7 0.056
1441876_x_at Zfp93 −2.8 3.4 −1.9 0.09
1419521_at Zfp94 3.8 0.0 2.2 0.002
The genes listed were found to be differentially expressed by microarray
analysis and real time quantitative RT–PCR as described in Materials and
methods.
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between the Foxa3 mutant mice and their littermate controls
(data not shown). Moreover, androgen receptor (AR) expression
was also unchanged in Leydig and Sertoli cells (see below and
Figs. 6e and f). The unchanged serum levels of these hormones
suggest that the abnormal spermatogenesis in Foxa3-deficient
mice is not an endocrine defect, but does not preclude a local
paracrine defect in growth factor or cytokine signaling within
the testis (see below).
Altered gene expression in Foxa3 null testes
In order to investigate the molecular link between Foxa3
deficiency and atrophy of the seminiferous tubules, weFig. 5. Foxa3 binding sites in the putative promotors of genes showing reduced stea
Numbers on the right give the position relative to the transcriptional start site. For 0
ends in light blue) and ATATGTTTATGT (starts in light blue, ends in dark blue). The p
(12 bp) are in color. TGTTT is the core motif for Foxa binding.performed expression profiling with testis RNA from wild
type and Foxa3−/− mice at the age of 8 months. Because of our
experience that isolation and culture of primary cells often
causes artefacts in microarray analyses, we decided to use total
testes RNA samples for expression profiling. While this strategy
is less sensitive to modulations of certain mRNAs that are
selectively changed in only one cell type and remain unchanged
in others, using this approach ensures that the results obtained
are based on biological effects and not on cell purification or
culture artefacts.
Overall, the gene expression profiles were similar between
wild type and homozygous mutant mice, indicating that there is
no global mis-regulation of transcription in Foxa3-deficient
testes. However, the mRNA levels of several genes specifically
expressed in germ and Leydig cells were significantly affected
by the absence of Foxa3 (Table 1). The changes in steady state
mRNA levels of the most relevant genes detected by microarray
analysis were confirmed independently by real time quantitative
RT–PCR (Table 1). The down-regulation of the genes identified
in this study was selective and not due to the loss of the cell
types expressing these genes since the steady state mRNA
levels of the vast majority of genes expressed in Leydig cells or
spermatids were not altered (e.g. protamines in spermatids and
enzymes of the testosterone synthesis pathway in Leydig cells).
Since the Foxa proteins are known as transcriptional
activators, we searched the promoter sequences of the genes
exhibiting reduced mRNA levels in the absence of Foxa3 for
consensus Foxa binding sites. We found such binding sites in
the putative promoter regions of all genes exhibiting reduced
steady state mRNA levels, suggesting a direct effect of the lack
of Foxa3 on the transcription of these genes (Fig. 5). The precisedy state mRNA levels in Foxa3-mutant testes. Binding sites are shown in color.
710005I19Rik, there are 2 overlapping sites. ATATATATGTTT (starts in green,
art in light blue is the overlap (ATATGTTT). For all others the full predicted sites
642 R. Behr et al. / Developmental Biology 306 (2007) 636–645mechanism of these regulatory relationships will need to be
established experimentally in the future.
The changes in gene expression, especially of the kallikrein
genes, provide a possible explanation of the phenotypic changes
described above. The kallikreins are a subgroup of the serine
protease enzyme family (Clements et al., 2004; Diamandis and
Yousef, 2002; Lundwall et al., 2006). Kallikreins are involved in
propeptide processing (Blaber et al., 1987; Lundwall et al., 2006;
Thomas et al., 1981) and have clinical relevance as prognostic
factors for several types of endocrine-related tumors such as
breast, ovarian and prostate cancer (Clements et al., 2004;
Diamandis and Yousef, 2002). Moreover, kallikreins have been
associated with such diverse biological processes as skin
desquamation, tooth development, neural plasticity, and Alzhei-Fig. 6. Degenerating seminiferous tubules in Foxa3-deficient testes re-express anti-
seminiferous tubule in the early phase of degeneration. The thickness of the germina
already occurred. Germ cells present in this tubule are mostly round spermatids as
spermatocytes) are rather rare. Germ cells are devoid of any pink stain (yellow arrows
Tubules with normal appearance do not exhibit any staining (lower left part). (b) A
generation of spermatocytes (presumably maturing to spermiation) is still present
cytoplasm is clearly stained by the AMH antibody (red arrow). (c) A tubule during d
tubule at the final stage of degeneration (yellow asterisk), which exhibits a Sertoli cel
the Sertoli cells have flattened and extend little beyond their nuclei. Again, AMH imm
Negative control omitting the AMH antibody from the diluent. Also, the adult wild ty
showed strong cytoplasmic Sertoli cell staining (data not shown). (e) Expression
immunohistochemistry. Sertoli cells (long red arrows), peritubular myoid cells (short
an 8-month-old mutant testis showing staining in the same cell types as the age-m
degenerated tubules still express the AR.mer's disease (Clements et al., 2004). Matsui and colleagues
(Matsui et al., 2000, 2005; Matsui and Takahashi, 2001) have
isolated three cDNAs from the mouse testis, Klk1b21, Klk1b24,
and Klk1b27 (formerly mGK-21 or mKlk21, mGK-24 or
mKlk24, and mGK-27 or mKlk27, respectively; Lundwall et
al., 2006), which are related to human kallikrein-1 and are
expressed in the testis exclusively in Leydig cells. We found all
three kallikreins expressed in mouse testes significantly
upregulated in the absence of Foxa3. Therefore, it is conceivable
that massively deregulated kallikrein expression disturbs
testicular function in Foxa3-deficient mice by paracrine
mechanisms. In fact, the kallikrein–kinin system has been
suggested previously to play an important role in paracrine
regulation of the seminiferous epithelium (Monsees et al., 1997).Müllerian hormone (AMH) as revealed by immunohistochemistry (a–d). (a) A
l epithelium appears to be normal, although vacuolization of the epithelium has
judged from nuclear morphology. Earlier germ cell stages (spermatogonia and
) but the surrounding cytoplasm of the Sertoli cells is clearly stained (red arrows).
degenerating tubule in a more advanced stage than that shown in panel a. One
in this tubule. Sertoli cell nuclei have aligned along the tubular wall and the
egeneration (red asterisk) still containing some germ cells (yellow arrows) and a
l-only phenotype characterized by the complete loss of germ cells. At this stage,
unoreactivity is widespread. Red arrows point out AMH positive Sertoli cells. (d)
pe control mice exhibited no staining while Sertoli cells in young testes up to p10
of the androgen receptor (AR; brown stain) in a wt testis as revealed by
red arrows) and Leydig cells (red asterisk) are AR positive. (f) AR expression in
atched wild type control. Remarkably, also Sertoli cells in almost completely
643R. Behr et al. / Developmental Biology 306 (2007) 636–645The relatively minor changes in the testicular transcriptome of
the mutant testes accompanied by the significant histological
impairments may be explained by the fact that the effects of
increased kallikrein activity in the testis affect primarily the
proteome.
Zinc finger proteins (Zfp) 93, 94, 95, and 96 are closely
related DNA binding proteins with predominant or exclusive
expression in testis (Shannon et al., 1996; Shannon and
Stubbs, 1998; Weissig et al., 2003). Zfp94 steady state mRNA
levels were increased approximately fourfold in Foxa3-mutant
mice compared to controls. In contrast, Zfp93 is strongly
down-regulated in the mutant testis. The Riken cDNA
0710005i19, which was down-regulated fourfold in the
Foxa3-deficient testes, encodes the mouse homolog of the
human MA2 antigen. Expression of MA2 in healthy tissues in
humans is restricted to the brain. However, in patients with
testicular cancer exhibiting concomitant neurological disorders
(paraneoplastic limbic and/or brain-stem encephalitis), MA2
antigen was also present in testicular tumors, suggesting a role
for MA2 during testicular tumorigenesis (Voltz et al., 1999).
Whether reduced MA antigen mRNA expression in Foxa3
mutant mice contributes to testicular germ cell loss remains to
be resolved.
Sertoli cells in degenerating tubules re-express anti-Müllerian
hormone
Although anti-Müllerian hormone (AMH) itself is not
essential for Sertoli cell differentiation (Behringer et al.,
1994), it is switched on very early in fetal Sertoli cells and is
a very reliable marker for the maturation state of this cell type
(Sharpe et al., 2003). In normal testis, AMH is specifically
expressed in immature Sertoli cells until puberty. With the
appearance of meiotic germ cells and androgen sensitivity of
Sertoli cells, AMH expression is strongly down-regulated in the
normal testis and mature Sertoli cells are devoid of AMH
(Sharpe et al., 2003). Interestingly, the Sertoli cells within the
Sertoli cell-only tubules in the Foxa3 mutant testes expressed
AMH protein as revealed by immunohistochemistry (Figs. 6a–
d). Moreover, AMH protein expression appeared to be induced
even where meiotic and postmeiotic germ cells were still
present (Figs. 6a and b), indicating that the loss of germ cells
was not the primary cause of AMH protein accumulation.
Likewise, transcriptional reactivation of the AMH locus is not a
likely explanation for the reappearance of AMH protein, as
mRNA levels were not altered in the mutants (data not shown).
The molecular mechanisms underlying the reappearance of the
AMH antigenicity in Sertoli cells remain to be investigated, but
it is tempting to speculate that increased kallikrein activity,
which alters the local crosstalk between Leydig and Sertoli
cells, may contribute to this effect.
Usually, AMH is down-regulated when Sertoli cells start
expressing the androgen receptor as a sign of maturity (Sharpe
et al., 2003). Interestingly, in Foxa3-deficient mice the Sertoli
cells in degenerated tubules still express the AR (Figs. 6e and f)
indicating an intermediate state of the Sertoli cells between
maturity and dedifferentiation.Summary and model of the progression of the testicular lesion
Foxa3 is expressed in spermatids and in Leydig cells.
According to our current view the lack of Foxa3 in Leydig cells
is causative for the phenotype described above. Since
spermiogenesis proceeds normal even in the absence of Foxa3
in spermatids, this transcription factor appears to be dispensable
in germ cells for completed spermatogenesis. However, lack of
Foxa3 in Leydig cells causes significantly increased Kallikrein
mRNA levels. We hypothesize that increased Kallikrein activity
in the mutant testes severely disturbs paracrine communication
between testicular cells. As a consequence, Sertoli cells may fail
to maintain their fully differentiated state, as evidenced by the
presence of AMH antigenicity, and lose their ability to support
and regulate the early steps of spermatogenesis, which leads to
an increase in germ cell apoptosis and eventually to degenera-
tion of seminiferous tubules.
Conclusions
In conclusion, we have shown that Foxa3 is necessary for
the maintenance of the testicular germ cell population and male
fertility in mice and provide evidence that the germinal
epithelium in testes lacking Foxa3 is not able to maintain its
differentiated phenotype. Surprisingly, Foxa3 is haploinsuffi-
cient in the testes, an unusual finding for transcription factors in
this organ. We have identified several differentially expressed
genes which may contribute to the phenotypic findings.
Strikingly, the mutant testes express increased levels of all
testicular kallikrein proteases, which may disturb the local
communication between the Leydig cells and the cells of the
seminiferous tubules. Approximately 8% of all men are infertile
and in a large subset of these patients the underlying cause is
unknown (Nieschlag, 2001). The phenotype of Foxa3-deficient
mice resembles a human spermatogenic disorder called mixed
atrophy, which is characterized by a variable degree of
degeneration of the seminiferous tubules. The molecular
mechanisms causing this disorder are unknown. However, it
is tempting to speculate that mixed atrophy in a subset of
patients may be caused by mutations in the FOXA3 locus.Materials and methods
Mice
The derivation of the Foxa3 null allele has been described (Kaestner et al.,
1998). Mice were genotyped by PCR on tail DNA as described previously. The
Foxa3 null allele was backcrossed to C57BL6 inbred mice for 11 generations to
obtain an incipient congenic strain (>99% C57BL6 contribution) prior to the
onset of this study. Use of an inbred background reduces the variability of the
phenotype, as all potential modifier loci are homozygous in all animals studied.
For genetic lineage tracing experiments, Foxa3-Cre mice (Lee et al., 2005) were
bred to Rosa26 lacZ reporter mice (Soriano, 1999). Testis from 3-month-oldmice
were prepared for β-galactosidase staining as described (Hiemisch et al., 1997).
Mating experiments
Age-matched males (n=8 in each group; +/+, +/−, −/−) from our Foxa3
breeding colony were housed together with age-matched CD1 females (Charles
644 R. Behr et al. / Developmental Biology 306 (2007) 636–645River). At the outset of the study male mice were 3 months of age, i.e. when the
phenotype became histologically evident. The study was continued for 5 months.
Three times a week all cages were inspected and pups counted. At 2 to 3 weeks
after birth the offspring were removed from the cages. At the termination of the
study the body weight and the paired testis weight of the male mice was
determined.
Hormone analysis
At termination of the mating experiments serum was collected from age-
matched males (n=6 per group) and levels of FSH, testosterone, and estradiol
were determined by AniLytics, Inc. (Gaithersburg, MD).
Histology and immunohistochemistry
After sacrifice of the mice the testes were removed and cut into halves. Two
halves were fixed in Bouin's solution for 4 h. One-half testis was fixed overnight
in 4% PFA, while the remaining half of was frozen at −80 °C. The fixed tissue
was paraffin-embedded and used for histological evaluation, detection of
apoptotic cells, and BrdU-localization. Immunohistochemistry was performed
on Bouin-fixed tissue essentially as described (Behr andWeinbauer, 1999) using
the primary antibody (sc-6886; Santa Cruz Biotechnology Inc.; CA, USA) to
detect anti-Müllerian hormone. As positive control we used newborn mouse
testis, where we obtained specific and exclusive staining of the Sertoli cells. In
negative controls the primary antibody was omitted. Androgen receptor was
detected similarly using the AR (N-20) antibody (sc-816; Santa Cruz
Biotechnology Inc.).
Proliferation assay
Proliferation of cells was detected by the incorporation of BrdU into
genomic DNA. A dose of 10 mg BrdU (Zymed)/kg bodyweight was
intraperitoneally injected 2 h before sacrifice. The tissue was fixed in 4% PFA
and paraffin-embedded. After re-hydration and antigen retrieval by cooking in a
microwave oven in 10 mM citric acid buffer, the BrdU antigen was detected
using an alkaline phosphatase-conjugated BrdU-specific antibody (Roche
Molecular Biochemicals). Histologically normal seminiferous tubules in
spermatogenic stages VII and VIII were evaluated. During these stages all
tubules exhibit BrdU-positive cells. Labeled cells were counted in at least 20
round tubular cross sections per animal (n=6 per group).
Apoptosis assay
Apoptotic cells were detected on Bouin-fixed tissue sections using the
TUNEL technique (Wijsman et al., 1993). Paraffin-embedded sections were
dewaxed and microwaved in 10 mM citric acid buffer for 8 min. For
visualization of DNA double strand breaks the in situ cell death detection kit
(Roche Molecular Biochemicals) was used according to the manufacturer's
protocol.
Microarray and RNA analysis
Four wild type and three Foxa3−/− testes samples, each containing 1 μg of
total RNA, were hybridized after a single round of amplification to Affymetrix
MOE430v2 oligo chips. Data was provided as absent/present calls and intensity
values. We normalized the data using the GeneChip Robust Multi-Array
Analysis (GCRMA) algorithm (Wu et al., 2003), implemented in a R package
(http://www.bioconductor.org/repository/devel/vignette/gcrma.pdf). Fold-
changes were calculated as the ratio of the geometric mean between wild type
and Foxa3−/− intensities.
Statistical analysis of the microarray data was completed using the
significance of microarrays (SAM) (Tusher et al., 2001) package with a false
discovery rate (FDR) of 10% and fold change cutoff of absolute value of 2.0.
Annotation for each ‘spot’ was downloaded from the Affymetrix web site. The
data have been deposited into ArrayExpress. Individual steady state transcript
levels were determined by real-time PCR (QPCR) using the SYBR Green
Master Mix from Stratagene on a Stratagene MX3000 QPCR instrument. RNaseprotection analysis was basically carried out as described previously (Kaestner
et al., 1994) using the RPAII kit from Ambion (Austin, TX, USA). The protected
RNA fragments were separated on 8 M urea denaturing 6% acrylamide gels and
the radioactive bands visualized using a PhosphoImager (Molecular Dynamics).
Primer sequences used can be obtained from Kaestner Lab website (http://www.
med.upenn.edu/kaestnerlab/reagents.shtml).
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